Susan Silbermann is President and General Manager of Pfizer Vaccines. In her role, Susan oversees a global business and is responsible for the commercial development of a visionary pipeline portfolio of preventative and therapeutic vaccines to address unmet medical needs and treat serious or life-threatening conditions. Susan leads a team that partners with government and global civic organizations to maximize Pfizer’s impact on public health. Pfizer is proud to collaborate with Gavi, the Vaccine Alliance, as we have a shared goal  ̶  “to protect the world’s most vulnerable children through a sustainable vaccine program.”  Through this collaboration, Pfizer contributes to Gavi’s goal of immunizing a further 300 million people from 2016 to 2020. Prior to this position, Susan was the regional president of Latin America within Pfizer’s Emerging Markets Business Unit. In this role, she managed Pfizer’s pharmaceutical operations in a diverse market with more than 20 countries, each with varying health needs and priorities.

 Research Interest On Biology